
Overview
Dr. Palmbos received his bachelor’s degree from Calvin College in Grand Rapids, Michigan where he graduated with honors in 2000. He completed his combined M.D. and Ph.D. degrees as part of a NIH sponsored medical scientist training program at the University of Michigan Medical School in Ann Arbor, Michigan in 2008. His graduate work focused on the nonhomologous endjoining pathway of DNA double strand break repair. He then completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan in 2010 and 2014 respectively. His clinical interest is genitourinary malignancies and he primarily sees patients with bladder and prostate cancers. His laboratory research focus is on bladder cancer and he is currently developing new preclinical models of bladder cancer and focusing on the role of a novel oncogene, ATDC, in bladder tumor development. He recently received American Society of Clinical Oncology (ASCO) Young Investigator and Bladder Cancer Advocacy Network (BCAN) Young Investigator awards and has an NIH K08 award to develop his research program.
Dr. Palmbos is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, and Cystectomy.
Dr. Palmbos is board certified in Internal Medicine and Medical Oncology. He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 2 clinical trials. Dr. Palmbos is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Palmbos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.
Frequently Asked Questions about Dr. Phillip L. Palmbos
How do I make an appointment with Dr. Phillip L. Palmbos?
You can book an appointment with Dr. Phillip L. Palmbos by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Phillip L. Palmbos a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Phillip L. Palmbos is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Phillip L. Palmbos specialize in?
While Dr. Phillip L. Palmbos is a Oncology, they have specific expertise in Bladder Cancer, Prostate Cancer, and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Phillip L. Palmbos participate in research or clinical trials?
Yes. Dr. Phillip L. Palmbos has published 39 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Phillip L. Palmbos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Phillip L. Palmbos accept my insurance?
Dr. Phillip L. Palmbos accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Palmbos isDistinguished. Learn about Bladder Cancer.
- Prostate CancerDr. Palmbos isDistinguished. Learn about Prostate Cancer.
- Advanced
- Familial Prostate CancerDr. Palmbos isAdvanced. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Palmbos isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Palmbos isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Urothelial CancerDr. Palmbos isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Palmbos isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Palmbos isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Bone TumorDr. Palmbos isExperienced. Learn about Bone Tumor.
- ChondrosarcomaDr. Palmbos isExperienced. Learn about Chondrosarcoma.
- Chromophobe Renal Cell CarcinomaDr. Palmbos isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Palmbos isExperienced. Learn about Clear Cell Sarcoma.
- Epithelioid SarcomaDr. Palmbos isExperienced. Learn about Epithelioid Sarcoma.
- Familial Wilms Tumor 2Dr. Palmbos isExperienced. Learn about Familial Wilms Tumor 2.
- FibrosarcomaDr. Palmbos isExperienced. Learn about Fibrosarcoma.
- GanglioneuroblastomaDr. Palmbos isExperienced. Learn about Ganglioneuroblastoma.
- GanglioneuromaDr. Palmbos isExperienced. Learn about Ganglioneuroma.
- LiposarcomaDr. Palmbos isExperienced. Learn about Liposarcoma.
- MelanomaDr. Palmbos isExperienced. Learn about Melanoma.
- Myxoid LiposarcomaDr. Palmbos isExperienced. Learn about Myxoid Liposarcoma.
- OsteosarcomaDr. Palmbos isExperienced. Learn about Osteosarcoma.
- Pancreatic CancerDr. Palmbos isExperienced. Learn about Pancreatic Cancer.
- Penile CancerDr. Palmbos isExperienced. Learn about Penile Cancer.
- Pulmonary EmbolismDr. Palmbos isExperienced. Learn about Pulmonary Embolism.
- Renal Cell Carcinoma (RCC)Dr. Palmbos isExperienced. Learn about Renal Cell Carcinoma (RCC).
- RetinoblastomaDr. Palmbos isExperienced. Learn about Retinoblastoma.
- Rhabdoid TumorDr. Palmbos isExperienced. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Palmbos isExperienced. Learn about Rhabdoid Tumor Predisposition Syndrome.
- RhabdomyosarcomaDr. Palmbos isExperienced. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Palmbos isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Synovial SarcomaDr. Palmbos isExperienced. Learn about Synovial Sarcoma.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Palmbos isExperienced. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Wilms TumorDr. Palmbos isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Palmbos isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.

